SATUDORA HOLDINGS CO., LTD. (JP:3544)
:3544
Want to see JP:3544 full AI Analyst Report?
Top Page
SATUDORA HOLDINGS CO., LTD.
(3544)
Select Model
Select Model
Rating:44Neutral
Price Target:
¥789.00
▼(-3.66% Downside)
Action:Reiterated
Date:06/21/26
The score is driven primarily by weak financial quality (very low margins, declining earnings, elevated leverage, and reduced/variable free cash flow) and a bearish technical setup (below major moving averages with negative momentum). Valuation is only moderately supportive with a modest dividend yield and a mid-range P/E.
Positive Factors
Stable revenue growth
Multi-year modest revenue growth shows the core drugstore retail model is holding volume and market position. That steady top-line reduces execution risk, supports predictable inventory and purchasing scale, and underpins medium-term cash flow planning despite low margins.
Negative Factors
Very thin and volatile net margins
Extremely low net margins leave little buffer against cost inflation, pricing pressure, or sales slippage. A small adverse shift in COGS or SG&A can wipe out profits, constraining retained earnings and making long-term profitability and strategic reinvestment fragile.
Read all positive and negative factors
Positive Factors
Negative Factors
Stable revenue growth
Multi-year modest revenue growth shows the core drugstore retail model is holding volume and market position. That steady top-line reduces execution risk, supports predictable inventory and purchasing scale, and underpins medium-term cash flow planning despite low margins.
Read all positive factors
SATUDORA HOLDINGS CO., LTD. (3544) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥11.22B
Dividend Yield1.24%
Average Volume (3M)29.60K
Price to Earnings (P/E)21.0
Beta (1Y)0.25
Revenue Growth0.40%
EPS Growth-43.15%
CountryJP
Employees1,107
SectorHealthcare
Sector Strength45
IndustryMedical - Pharmaceuticals
Share Statistics
EPS (TTM)52.77
Shares Outstanding14,236,564
10 Day Avg. Volume15,720
30 Day Avg. Volume29,603
Financial Highlights & Ratios
PEG Ratio-0.60
Price to Book (P/B)1.12
Price to Sales (P/S)0.11
P/FCF Ratio23.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SATUDORA HOLDINGS CO., LTD. Business Overview & Revenue Model
Company Description
Satudora Holdings Co., Ltd. is a Japanese enterprise primarily focused on operating drugstores and dispensing pharmacies. Its business operations are structured into two main divisions: Retail Business and IT Solution Business. Beyond its core ret...
How the Company Makes Money
null...
SATUDORA HOLDINGS CO., LTD. Financial Statement Overview
Summary
Income Statement
48
Neutral
Balance Sheet
42
Neutral
Cash Flow
39
Negative
| Breakdown | TTM | May 2025 | May 2024 | May 2023 | May 2022 | May 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 100.56B | 100.57B | 100.17B | 95.52B | 87.48B | 82.91B |
| Gross Profit | 25.82B | 26.11B | 24.29B | 22.31B | 20.03B | 18.89B |
| EBITDA | 2.78B | 3.00B | 2.80B | 2.36B | 1.58B | 1.73B |
| Net Income | 732.00M | 434.00M | 768.00M | 470.00M | 87.00M | 317.00M |
Balance Sheet | ||||||
| Total Assets | 46.90B | 45.15B | 46.45B | 45.14B | 43.28B | 41.59B |
| Cash, Cash Equivalents and Short-Term Investments | 3.05B | 1.48B | 2.67B | 2.67B | 2.31B | 2.96B |
| Total Debt | 15.00B | 15.23B | 17.21B | 17.39B | 18.11B | 13.88B |
| Total Liabilities | 37.05B | 34.93B | 36.52B | 35.90B | 34.44B | 32.70B |
| Stockholders Equity | 9.72B | 10.11B | 9.80B | 9.13B | 8.73B | 8.80B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 474.00M | 1.32B | 2.10B | -3.81B | -602.00M |
| Operating Cash Flow | 0.00 | 2.32B | 2.60B | 3.54B | -1.77B | 1.28B |
| Investing Cash Flow | 0.00 | -1.14B | -1.67B | -1.92B | -2.87B | -2.23B |
| Financing Cash Flow | 0.00 | -2.37B | -935.00M | -1.26B | 4.00B | 1.27B |
SATUDORA HOLDINGS CO., LTD. Technical Analysis
Negative
819.00
Price Trends
842.34
Negative
844.06
Negative
826.00
Negative
Market Momentum
-1.65
Positive
37.00
Neutral
34.52
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3544, the sentiment is Negative. The current price of 819 is below the 20-day moving average (MA) of 830.80, below the 50-day MA of 842.34, and below the 200-day MA of 826.00, indicating a bearish trend. The MACD of -1.65 indicates Positive momentum. The RSI at 37.00 is Neutral, neither overbought nor oversold. The STOCH value of 34.52 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:3544.
SATUDORA HOLDINGS CO., LTD. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | ¥443.37B | 13.84 | 11.37% | 3.04% | 5.08% | 2.07% | |
67 Neutral | ¥343.74B | 17.76 | ― | 0.41% | 14.59% | 7.84% | |
66 Neutral | ¥591.25B | 12.16 | 15.71% | 0.96% | 15.07% | 72.98% | |
62 Neutral | ¥887.45B | 22.05 | ― | 1.72% | ― | ― | |
60 Neutral | ¥477.20B | 15.18 | ― | 0.93% | 6.74% | 6.60% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
44 Neutral | ¥11.22B | 20.97 | ― | 1.24% | 0.40% | -43.15% |
* Healthcare Sector Average
JP:3544
SATUDORA HOLDINGS CO., LTD.
813.00
-46.41
-5.40%
JP:9989
Sundrug Co
3,792.00
-492.29
-11.49%
JP:7649
Sugi Holdings Co
3,137.00
-58.42
-1.83%
JP:3391
TSURUHA Holdings
1,972.50
-262.78
-11.76%
JP:3349
COSMOS Pharmaceutical Corporation
5,995.00
-3,034.08
-33.60%
JP:3549
KUSURI NO AOKI HOLDINGS CO.,LTD.
3,595.00
78.65
2.24%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.